Back to search

Article

The Aftermath of Tapering Tocilizumab After Achieving Treatment Target In Patients With Rheumatoid Arthritis: A Nationwide Cohort Study

2021-10-25

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Although recent guidelines recommend that tapering of biologic disease-modifying anti-rheumatic drugs (bDMARDs) can be considered in patients with rheumatoid arthritis (RA), there has been little evidence supporting the strategy during the non-tumor necrosis factor inhibitor treatment. This study aims to investigate the effectiveness and safety of tapering tocil...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6e246e9c-2112-5c89-ba5d-df4c3aa81cf0
DOI
10.21203/rs.3.rs-955242/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Aftermath of Tapering Tocilizumab After Achieving Treatment Target In Patients With Rheumatoid Arthritis: A Nationwide Cohort StudyDOI 10.21203/rs.3.rs-955242/v1
Differential long-term retention of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis by age group from the FIRST registrySemantic proximity
Influence of IL6R gene polymorphisms in the effectiveness to treatment with tocilizumab in rheumatoid arthritis.Semantic proximity
Differences and Similarities in Clinical and Functional Responses Among Patients Receiving Tofacitinib Monotherapy, Tofacitinib Plus Methotrexate, and Adalimumab Plus Methotrexate: A Post-hoc Analysis of Data From Oral StrategySemantic proximity
Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomySemantic proximity
Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?Semantic proximity
How to Define Boolean Low Disease Activity in Rheumatoid Arthritis: Experience from a Large Real-World CohortSemantic proximity
Effectiveness and Safety of Intravenous Golimumab With and Without Concomitant Methotrexate in Patients With Rheumatoid Arthritis in the Prospective, Noninterventional AWARE StudySemantic proximity
Relationships of serum levels of tocilizumab to interleukin-6 and endogenous markers of CYP3A activity in patients with rheumatoid arthritis.Semantic proximity
Concomitant Sjögren’s disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss Clinical Quality Management cohortSemantic proximity
Real-World Use of Rituximab in Rheumatoid Arthritis: A 3-Year Analysis from the RBSMR Biologic RegistrySemantic proximity
Unincreased mortality of patients with early rheumatoid arthritis compared to the general population in the past two decades: results from a Japanese prospective observational cohort: IORRASemantic proximity
The effectiveness of tocilizumab in treating refractory adult-onset Still's disease with dichotomous phenotypes: IL-18 is a potential predictor of therapeutic response.Semantic proximity
Select a neighboring publication to make it the new centre.